MedPath

Yonsei University

Yonsei University logo
🇰🇷South Korea
Ownership
Private
Established
1885-01-01
Employees
5K
Market Cap
-
Website
http://www.yonsei.ac.kr

Development and Clinical Validation of Ketogen-based Therapeutic Diet for Pancreaticobiliary Cancer Patients

Not Applicable
Completed
Conditions
Ketogen-based Therapeutic Diet
Pancreaticobiliary Cancer
Interventions
Dietary Supplement: Modified Atkin's Diet
Dietary Supplement: Ketogenic Diet
Dietary Supplement: Ordinary Diet
First Posted Date
2016-11-16
Last Posted Date
2018-03-15
Lead Sponsor
Yonsei University
Target Recruit Count
30
Registration Number
NCT02964806
Locations
🇰🇷

Severance Hospital, Seoul, Korea, Republic of

Selection Criteria in Endovascular Thrombectomy and Thrombolytic Therapy (SECRET) Study: Development of Patient Selection Criteria Using CT Images and Accompanying Diseases for Efficient Intravenous Thrombolytic and Intra-arterial Recanalization Therapy in Acute Ischemic Stroke

Completed
Conditions
Ischemic Stroke
Interventions
Other: Brain CT imaging
First Posted Date
2016-11-15
Last Posted Date
2022-12-28
Lead Sponsor
Yonsei University
Target Recruit Count
1359
Registration Number
NCT02964052
Locations
🇰🇷

Department of Neurology, Yonsei University College of Medicine, Seoul, Korea, Republic of

Effectiveness of Prophylactic Antibiotics to Prevent Post Endoscopic Retrograde Cholangio Pancreatography Bacteremia in Biliary Obstruction Patient

Not Applicable
Conditions
Bile Duct Cancer Resectable
Klatskin Tumor
Biliary Obstructive Disease Such as Choledocholithiasis
Peri-ampullary Cancer
Benign Biliary Stricture
Interventions
Biological: Placebo
Biological: Pacetin® (cefoxitin)
First Posted Date
2016-11-08
Last Posted Date
2019-01-16
Lead Sponsor
Yonsei University
Target Recruit Count
400
Registration Number
NCT02958059
Locations
🇰🇷

Yonsei university of medical center, Seoul, Korea, Republic of

Biomarker-Integrated Umbrella, Advanced Gastric Cancer

Not Applicable
Completed
Conditions
Gastric Cancer
Interventions
Other: biomarker screening
First Posted Date
2016-11-01
Last Posted Date
2024-12-30
Lead Sponsor
Yonsei University
Target Recruit Count
400
Registration Number
NCT02951091
Locations
🇰🇷

Severance Hospital, Yonsei University Health System, Yonsei Cancer Center, Seoul, Korea, Republic of

The Effect of Digital Rehabilitation System With Wearable Multi-IMU (Inertial Measurement Unit) Sensors on Upper Limb Functions in Children With Brain Injury

Not Applicable
Completed
Conditions
Cerebral Palsy
Children With Brain Injury
Interventions
Other: Conventional OT group
Device: digital rehabilitation system with wearable multi-IMU(inertial measurement unit) sensors (Rapael kids)
First Posted Date
2016-10-31
Last Posted Date
2018-07-19
Lead Sponsor
Yonsei University
Target Recruit Count
40
Registration Number
NCT02949817
Locations
🇰🇷

Severance Hospital, Seoul, Korea, Republic of

Effect of Lipid Modifying Drugs on HDL Function in Patients With Hyperlipidemia

Not Applicable
Completed
Conditions
Hyperlipidemia
Interventions
Drug: Concurrent with Atorvastatin 5 mg + Ezetimibe 10 mg
Behavioral: Lifestyle modification
First Posted Date
2016-10-24
Last Posted Date
2018-07-18
Lead Sponsor
Yonsei University
Target Recruit Count
58
Registration Number
NCT02942602
Locations
🇰🇷

Division of Cardiology, Department of Internal Medicine,, Seoul, Korea, Republic of

Evaluating the Effect of Laser Vision Surgery, Phakic Intraocular Lens Implantation, Cataract Surgery, and Pupil Dilation on the Iris Recognition Scanner Function of Smartphone

Not Applicable
Completed
Conditions
Cataract
Myopia
Myopic Astigmatism
Interventions
Device: iris recognition scanner
First Posted Date
2016-10-19
Last Posted Date
2018-07-18
Lead Sponsor
Yonsei University
Target Recruit Count
25
Registration Number
NCT02939001
Locations
🇰🇷

Institute of Vision Research, Department of Ophthalmology, Yonsei University College of Medicine, Seoul, Korea, Republic of

Efficacy of Partial Covered Double Bare Metal Stent Compared to Uncovered Double Bare Metal Stent in Malignant Biliary Obstruction

Not Applicable
Conditions
Malignant Tumor
Interventions
Device: Stenting by ERCP (endoscopic retrograde cholangiopancreatography)
Device: SEMS(self-expandable metallic stent)
First Posted Date
2016-10-18
Last Posted Date
2019-06-24
Lead Sponsor
Yonsei University
Target Recruit Count
260
Registration Number
NCT02937246
Locations
🇰🇷

Severance Hospital, Yonsei University, Seoul, Korea, Republic of

Machine Learning for Identification of Future Disease Development: A Nationwide Cohort Study (MILESTONE)

Conditions
Cardiovascular Disease
Metabolic Disease
First Posted Date
2016-10-13
Last Posted Date
2018-01-10
Lead Sponsor
Yonsei University
Target Recruit Count
510000
Registration Number
NCT02931500
Locations
🇰🇷

Yonsei University Severance Hospital, Seoul, Korea, Republic of

The Effect of Remifentanil-dexmedetomidine Compared With Remifentanil-midazolam on Patient's Satisfaction

Not Applicable
Completed
Conditions
Peripheral Arterial Occlusive Disease
Interventions
First Posted Date
2016-10-10
Last Posted Date
2019-01-10
Lead Sponsor
Yonsei University
Target Recruit Count
70
Registration Number
NCT02929095
Locations
🇰🇷

Department of Anaesthesiology and Pain Medicine, Yonsei University College of Medicine, Seoul, Korea, Republic of

© Copyright 2025. All Rights Reserved by MedPath